Skip to content

The Actual News

Stay informed without the news wearing you out.

Trump cuts drug price deal with Regeneron

Trump cuts drug price deal with Regeneron

Summary

President Trump announced a deal with drug company Regeneron to lower prices on certain medicines. This deal is the last in a series of agreements with 17 companies aimed at reducing drug costs for Medicaid patients and some others.

Key Facts

  • President Trump secured a drug price deal with Regeneron, completing agreements with 17 drug manufacturers.
  • These deals aim to lower prices for certain drugs offered to Medicaid and cash-paying patients using the TrumpRx website.
  • The administration says the combined agreements cover 86% of brand-name drugs.
  • Most discounts do not apply to people with private insurance or Medicare.
  • Experts say Medicaid prices are already low, so the discounts may not significantly affect drug companies’ profits.
  • Democrats want the details of these confidential agreements made public to check their impact.
  • Smaller biotech companies might also make deals to avoid new tariffs on drugs.
Read the Full Article

This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.

The week's biggest stories, one calm email every Monday.